SQSTM1 and neoplasm: Most intriguingly, 5 mg/kg sepantronium bromide therapy in tamoxifen-induced double knock-out mice for TGFBR1 and PTEN limits tumor growth and mTOR phosphorylation at Ser-2448 and SQSTM1/p62 immunohistochemistry [103].